📖 Approx. 8 minutes
Current Status and Future Prospects of Medical M&A in Kanagawa Prefecture
Kanagawa Prefecture, particularly urban areas like Yokohama and Kawasaki, is experiencing population growth and an aging demographic, leading to sustained high demand for medical institutions. Against this backdrop, M&A (Mergers and Acquisitions) and business succession are becoming crucial options for medical corporations and clinic directors aiming to maintain or develop regional healthcare, or to expand their businesses. However, understanding the complex regulations, business customs unique to the medical industry, and the medical fee system is essential, making it difficult to proceed without specialized knowledge. This article, focusing on Kanagawa Prefecture, especially the Yokohama and Kawasaki areas, will be explained by M&A Medical, an M&A support organization specializing in the medical industry, covering market trends, demand dynamics, and key points for successful succession.
Characteristics and Market Trends of Medical Corporation M&A in Kanagawa Prefecture
Kanagawa Prefecture, particularly Yokohama and Kawasaki, are urban areas with diverse regional healthcare needs, making a wide range of medical institutions potential M&A targets. Generally, the “market price” for medical corporation M&A is calculated by comprehensively evaluating factors such as net assets, profitability, location, medical specialties, and future potential. In high-demand regions like Kanagawa Prefecture, profitable clinics and community-based hospitals tend to receive higher valuations.
The common M&A scheme is “transfer of equity interests” in a medical corporation. However, due to the nature of medical corporations, the “business” itself is often the subject of transfer. In the case of equity interest transfers, complex tax issues such as inheritance tax, gift tax, and capital gains tax are involved. Specifically, the taxation of capital gains differs for individuals and medical corporations, making collaboration with experts indispensable. The valuation of equity interests can fluctuate significantly depending on factors like hidden gains, debt status, and future earnings projections, making it difficult to state a definitive price. However, it is common for the valuation to be based on net assets multiplied by a certain factor. This is a simplified assessment, and actual transactions involve more detailed due diligence (DD) and individual condition negotiations.
Demand for medical M&A in Kanagawa Prefecture is expected to remain strong, driven by the need for succession among institutions lacking successors and the demand from corporations seeking business expansion or new market entry. Especially with the current high hurdles for opening clinics in urban areas, the trend of acquiring existing clinics or hospitals through M&A to quickly establish a business base may accelerate.
| Evaluation Item | Details | Market Trend (Estimate) |
|---|---|---|
| Net Assets | Amount of assets minus liabilities on the books. Presence of hidden gains is important. | Net Assets + α |
| Profitability | Ordinary profits and medical fee revenue over the past few years. Stability is valued. | Several years of annual profit |
| Location | Demographics, competitive landscape, transportation access, future potential. | Varies greatly by region |
| Medical Specialty/Expertise | High-demand specialties, level of expertise. | (Tendency to add to valuation) |
| Licenses/Notifications | Clinic opening permits, status of various notifications. | (Essential for smooth succession) |
| Others | Condition of facilities, employee handover, brand image, etc. | (Matters for individual negotiation) |
Specific Succession Process and Points to Note for Medical Corporations
M&A and business succession of medical corporations, especially succession, involve unique processes and considerations different from those of regular companies. Firstly, medical corporations have a “member” system, with the general meeting of members being the highest decision-making body. In the case of equity interest transfer, procedures for changing members are required. Furthermore, some medical corporations may have a “fund” system, and careful consideration is needed for the return of these funds. Funds are contributions from stakeholders, and their return requires attention to tax implications (e.g., deemed dividend taxation).
Moreover, revisions to medical fee schedules directly impact the profitability of medical institutions, making it crucial to scrutinize future medical fee prospects during M&A timing and due diligence. Changes in facility standards or additional fee requirements, as well as the reorganization of bed functions based on regional healthcare plans, can also affect business continuity and future prospects. Regarding licenses and notifications, confirmation with the relevant authorities and preparation of procedures in advance are necessary to ensure smooth handover after succession. M&A Medical provides detailed support in collaboration with a team of experts (lawyers, tax accountants, certified public accountants, etc.), taking into account these unique aspects of medical corporations. We stand by both buyers and sellers, facilitating smooth and appropriate M&A and business succession from multifaceted perspectives including legal regulations, taxation, finance, and medical law.
Steps for M&A and Business Succession and How to Proceed in Kanagawa Prefecture
Medical M&A and business succession generally proceed in the following steps. While this basic flow is common in Kanagawa Prefecture, expert support becomes even more crucial for region-specific healthcare circumstances and administrative coordination.
- Setting M&A/Business Succession Objectives and Information Gathering
First, clearly define what you aim to achieve through M&A or business succession. The optimal scheme and counterparty will differ depending on objectives such as business expansion, resolving succession issues, or contributing to regional healthcare. - Consultation with Experts (M&A Intermediaries, Lawyers, Tax Accountants, etc.)
Consult with experts experienced in medical M&A to analyze the current situation, understand market trends, and consider M&A schemes. M&A Medical offers initial consultations free of charge. - Searching for and Screening Counterparty Candidates
Utilize the network and proprietary database of experts to find potential counterparties that meet the criteria. Detailed information will be disclosed to potential sellers after signing a Non-Disclosure Agreement (NDA). - Signing a Memorandum of Understanding (MOU)
Agree on the basic terms of the M&A (transaction price, scheme, key clauses, etc.) with the interested counterparty. - Conducting Due Diligence (DD)
The buyer conducts a detailed investigation of the seller’s business, finances, legal affairs, tax matters, and medical legal aspects. Potential risks and issues will be identified at this stage. - Signing the Final Agreement (SPA)
Based on the DD results, final negotiations are conducted, and a Share Purchase Agreement (SPA) or similar contract is signed. - Closing (Transaction Execution)
In accordance with the agreement, payment of consideration, transfer of shares/business, and procedures for inheriting licenses are carried out. - Post-Merger Integration (PMI)
The integration process after M&A. Smooth integration of organization, systems, and culture to maximize synergy effects.
In Kanagawa Prefecture, M&A and business succession require particular emphasis on coordination with administrative bodies in line with regional healthcare plans, and specialized knowledge regarding medical fees and facility standards. M&A Medical supports the smooth handling of administrative procedures and the formulation of future-oriented business plans by leveraging a network of experts familiar with the region.
Impact of Medical Fee Revisions and Regional Healthcare Plans
In the management of medical institutions, revisions to medical fee schedules are unavoidable and significant factors. Recent revisions have included the promotion of home healthcare, strengthening of primary care physician functions, and increased use of ICT. These revision details directly impact the profitability and future prospects of medical institutions targeted for M&A. For example, clinics strong in home healthcare may benefit more from revisions, while hospitals with inpatient functions will face greater scrutiny regarding the reorganization of bed functions and alignment with regional healthcare plans.
Regional healthcare plans are plans formulated by each prefecture outlining the future vision of healthcare provision. In Kanagawa Prefecture, the differentiation and collaboration of bed functions, and the strengthening of collaboration with home healthcare and long-term care are being promoted. When considering M&A, sufficient consideration must be given to alignment with these regional healthcare plans. Understanding the role the target medical institution should or can play within the plan is key to increasing the success rate of M&A. M&A Medical provides comprehensive advice, including post-acquisition business plan development, based on the latest medical fee revision trends and regional healthcare plans.
Points to Note When Acquiring a Medical Corporation: Licenses and Business Tax
When acquiring a medical corporation through M&A, particular attention must be paid to the handling of “licenses” and “business tax.” Administrative licenses such as clinic opening permits, hospital opening permits, and various designations (e.g., insured medical institution, psychiatric emergency medical institution) are essential for the establishment and operation of medical institutions. These licenses are generally not transferable and must be reacquired or renewed by the buyer. Delays or deficiencies in these procedures can have a significant impact on business continuity, making prior confirmation with the local health department and relevant authorities mandatory. M&A Medical collaborates with experts in license succession to support smooth procedures.
Additionally, “business tax” may be levied on medical corporations. While medical corporations generally benefit from reduced corporate tax rates due to their non-profit nature, certain business activities (e.g., sales of pharmaceuticals or medical devices) may be subject to business tax. In the case of equity interest transfer, capital gains tax (separate taxation) is generally levied on the portion where the transfer price exceeds the acquisition cost. However, it is essential to thoroughly check for the existence of business tax on the medical corporation and potential future tax risks during due diligence. Understanding and addressing tax risks in advance can prevent unexpected burdens after M&A.
Conclusion: Consult Experts for Medical M&A and Business Succession in Kanagawa Prefecture
Medical M&A and business succession in Kanagawa Prefecture, especially in the Yokohama and Kawasaki areas, can be highly effective means for maintaining and developing regional healthcare and achieving sustainable growth for medical institutions. However, specialized knowledge and experience are indispensable for accurately understanding and appropriately proceeding with the complex regulations, medical fee systems, regional healthcare plans, and tax issues unique to the medical industry. M&A Medical, as a certified M&A support organization by the Small and Medium Enterprise Agency, offers specialized services for M&A and business succession of medical corporations and clinics. We also offer free consultations, so please feel free to contact us first.
Consult M&A Medical for Medical Succession
M&A Medical is a specialized M&A and business succession support service for medical institutions. As a certified M&A support organization by the Small and Medium Enterprise Agency, we support everything from the transfer of clinics and medical corporations struggling with successor shortages to strategic acquisitions on a success-fee basis.
- Initial Consultation and Preliminary Appraisal are Free
- No upfront or monthly fees (Success fee only)
- Strict Confidentiality (Proceeding after NDA signing)
- Service available nationwide (all 47 prefectures) and for all medical specialties
Please consult us early, even if you only want to know the market trends, lack a successor, or are considering joining a group.